Last week, readers were most interested in an update from ESCMID on companies' plans for their rapid molecular diagnostic platforms and tests.

NEW YORK — Digital pathology company Techcyte said on Thursday that it has raised $15 million in private financing. The funding round was led by Van Tuyl Companies and included existing investors Mayo ...

The 510(k) clearances were granted to a dozen in vitro diagnostic tests and reagents which used a variety of detection methods and approaches.

NEW YORK – Laboratory Corporation of America on Thursday raised its full-year 2026 guidance, projecting revenue of between $14.65 billion and $14.80 billion, which at the midpoint would mean year-over ...

The advanced diagnostics space was something of an exception, however, as these stakeholders signaled more openness to the idea, though not without reservations.

Comprising more than 20 firms and organizations across the infectious disease space, the compact will address issues like test access and data fragmentation.

Eand arlier this month, the CDC said it was temporarily pausing testing for a range of diseases including rabies, poxviruses, the Epstein-Barr virus.

Last week, readers were most interested in an update from Roche at ESCMID about its tuberculosis testing business.

MUNICH – When the decision was made to create and implement new regulations for in vitro diagnostics in the European Union several years ago, the intention was to improve testing accuracy and patient ...

The blood-based test is designed to help differentiate between schizophrenia and bipolar I disorder in patients with symptoms.